Guardant Health, Inc. (GH) fundamentals score
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. It is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Services-Medical Laboratories · Healthcare · Listed on NASDAQ
Overall: 5.0 out of 10, Mixed fundamentals
- Growth: 5.6/10
- Profitability: 4.1/10
- Financial health: 4.9/10
- Earnings quality: 7.0/10
- Valuation: 3.5/10
Scores are calculated from Guardant Health, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10